Search for: "Grant v. Bristol-Myers Squibb" Results 1 - 20 of 140
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Mar 2020, 2:33 pm by Wystan Ackerman
Circuit and Seventh Circuit issued decisions addressing a question that has been hotly debated by class action lawyers on the plaintiffs’ and defense sides: whether the Supreme Court’s decision on personal jurisdiction in Bristol-Myers Squibb Co. v. [read post]
24 Jul 2008, 11:36 am
Bristol Myers Squibb, No. 07-2723 (7/23/08) affirms a grant of summary judgment (first rejected by a magistrate judge) to the defendant in a gender discrimination case. [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
20 Jan 2017, 4:26 am by Edith Roberts
In The National Law Journal (subscription or registration required), Tony Mauro reports on one of the grants, Bristol-Myers Squibb Co. v. [read post]
21 Jan 2007, 10:48 am
The story also said: Bristol-Myers and Sanofi are widely expected to win their patent case. [read post]
Supreme Court established limitations on personal jurisdiction over non-resident corporate defendants in state court “mass” actions in Bristol-Myers Squibb Co. v. [read post]
19 Mar 2012, 4:16 am
Judge Birss QC assures us that his decision in Merck Sharp Dohme Corp & Anor v Teva Pharma BV & Anor [2012] EWHC 627 (Pat), relating to an application by Bristol-Myers Squibb for an interim injunction pending trial, raises no issue of principle, but he does provide an enlightening discussion of how to address some issues of fact that are common in an application for a quia timet injunction, including a review of the European case law. [read post]
29 Nov 2019, 1:34 am
With the addition of the EU as the 15th member, the Act can now enter into force.PatentsOn the SpicyIP blog, Pankhuri Agarwal reported on the Delhi High Court’s decision in Bayer Healthcare and Bristol Myers Squibb v. [read post]
25 Apr 2017, 3:39 am by Edith Roberts
First up is Bristol-Myers Squibb Co. v. [read post]